Title:
GLYX-13 PREPARATION METHOD AND INTERMEDIATE COMPONENT THEREOF
Document Type and Number:
WIPO Patent Application WO/2018/210336
Kind Code:
A1
Abstract:
A GLYX-13 preparation method and an intermediate compound thereof. According to the provided method, Fmoc-O-tert-butyl-L-threonine, Fmoc-L-proline, N-carboxybenzyl-L-threonine amide, and proline benzyl ester hydrochloride are used as starting materials; in virtue of eight easy-to-operate and economical synthetic steps, GLYX-13 can be prepared on a commercial scale and with a high yield, without using any expensive peptide condensation agent or any controlled precursor or aggressive deprotection agent.
Inventors:
LIU JINGJIAN (CN)
ZHANG LIANGREN (CN)
ZHANG GUISEN (CN)
WANG GUOHAI (CN)
ZHANG LIANGREN (CN)
ZHANG GUISEN (CN)
WANG GUOHAI (CN)
Application Number:
PCT/CN2018/087487
Publication Date:
November 22, 2018
Filing Date:
May 18, 2018
Export Citation:
Assignee:
NHWA PHARMA CORP (CN)
UNIV BEIJING (CN)
UNIV BEIJING (CN)
International Classes:
A61K38/07; C07K5/103; A61P25/24; C07K1/06
Domestic Patent References:
WO2016014982A1 | 2016-01-28 | |||
WO2013063120A2 | 2013-05-02 |
Foreign References:
CN107474107A | 2017-12-15 | |||
CN104109189A | 2014-10-22 |
Attorney, Agent or Firm:
NTD UNIVATION INTELLECTUAL PROPERTY AGENCY LTD. (CN)
Download PDF: